Page last updated: 2024-10-26

dipyridamole and Papulosquamous Disorders

dipyridamole has been researched along with Papulosquamous Disorders in 4 studies

Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's3 (75.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ojeda Cuchillero, RM1
Sánchez Regaña, M1
Umbert Millet, P1
Kocheril, SV1
Blaivas, M1
Appleton, BE1
McCune, WJ1
Ike, RW1
Requena, L1
Fariña, C1
Barat, A1
Torrelo, A1
Sevilla, J1
Mediero, IG1
Candelas, D1
Zambrano, A1

Other Studies

4 other studies available for dipyridamole and Papulosquamous Disorders

ArticleYear
Benign cutaneous Degos' disease.
    Clinical and experimental dermatology, 2003, Volume: 28, Issue:2

    Topics: Adult; Aspirin; Dipyridamole; Humans; Male; Platelet Aggregation Inhibitors; Skin Diseases, Papulosq

2003
Degos' disease mimicking vasculitis.
    Arthritis and rheumatism, 2004, Jun-15, Volume: 51, Issue:3

    Topics: Abdominal Pain; Diagnosis, Differential; Dipyridamole; Drug Administration Schedule; Fatal Outcome;

2004
Degos disease in a patient with acquired immunodeficiency syndrome.
    Journal of the American Academy of Dermatology, 1998, Volume: 38, Issue:5 Pt 2

    Topics: Acquired Immunodeficiency Syndrome; Atrophy; Cicatrix; Dipyridamole; Erythema; Homosexuality, Male;

1998
Malignant atrophic papulosis in an infant.
    The British journal of dermatology, 2002, Volume: 146, Issue:5

    Topics: Aspirin; Dipyridamole; Drug Therapy, Combination; Female; Humans; Infant; Platelet Aggregation; Plat

2002